Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates

Journal of Clinical Microbiology

Volumn 37, Issue 6, 1999, Pages 2109-2110

  Da Silva, Gabriela J ^a   Leitão, Rui ^a   Peixe, Luísa ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; NITROCEFIN; PIPERACILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS);

EID: 0032958777     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.6.2109-2110.1999     Document Type: Article

References (10)

1. Bush, K. 1998. Metallo-β-lactamases: a class apart. Clin. Infect. Dis. 27 (Suppl. 1):S48-S53.
2. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
3. Clark, R. B. 1996. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of 33-36 KDa outer-membrane protein. J. Antimicrob. Chemother. 38:245-251.
4. Forster, D. H., and F. D. Daschner. 1998. Acinetobacter species as nosocomial pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 17:73-77.
5. Gehrlein, M., H. Leying, W. Cullman, S. Wendt, and W. Opferkuch. 1991. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy 37:405-412.
6. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing: eighth informational supplement. NCCLS document M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Paton, R., R. S. Miles, J. Hood, and S. G. B. Amyes. 1993. ARI-I: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
8. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37:750-753.
9. Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Vergara, R. Reig, R. Gomez-Lus, and M. T. Jimenez de Anta. 1993. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyl-transferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
10. Weinbren, M. J., A. P. Johnson, M. E. Kaufmann, and D. M. Livermore. 1998. Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit. J. Antimicrob. Chemother. 41:574-576.